Please login to the form below

Not currently logged in
Email:
Password:

sugammadex

This page shows the latest sugammadex news and features for those working in and with pharma, biotech and healthcare.

FDA approvals hit 19-year high

FDA approvals hit 19-year high

Among these, the FDA highlighting Merck &Co's neuromuscular blockade reversal agent Bridion (sugammadex), Pfizer's CD4/6 inhibitor Ibrance (palbociclib) for breast cancer and Boehringer Ingelheim's Praxbind (idarucizumab), a

Latest news

More from news
Approximately 3 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics